Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 Apr 21;18(5):1448–1456. doi: 10.1158/1055-9965.EPI-08-0936

Table 4.

Risk of endometrial cancer in relation to the use of other medications

N cases N controls Age and BMI adjusted OR*(95%CI)
Pain and inflammation
NSAIDs P(trend duration) = 0.12
 No 373 353 1.0 (ref.)
 Yes 96 114 0.7 (0.5–0.97)
 Aspirin
 No 413 391 1.0 (ref.)
 Yes 56 76 0.7 (0.4–1.0)
 Non-aspirin NSAIDs
 No 429 429 1.0 (ref.)
 Yes 40 38 0.8 (0.5–1.3)
Analgesics
 No 451 455 1.0 (ref.)
 Yes 18 12 1.2 (0.5–2.7)
Corticosteroids
 No 447 450 1.0 (ref.)
 Yes 22 17 1.1 (0.5–2.1)
Mood disorders
Serotonin selective reuptake inhibitors
 No 421 423 1.0 (ref.)
 Yes 48 44 0.9 (0.6–1.4)
Benzodiazepines
 No 445 441 1.0 (ref.)
 Yes 24 26 0.9 (0.5–1.7)
Gastrointestinal
Proton pump inhibitors
 No 442 436 1.0 (ref.)
 Yes 27 31 0.7 (0.4–1.2)
*

adjusted for age (linear spline) and BMI in 4 categories